Publication details
Nová doporučení v léčbě srdečního selhání
| Title in English | New recommendation in the treatment of heart failure |
|---|---|
| Authors | |
| Year of publication | 2017 |
| Type | Article in Periodical |
| Magazine / Source | Acta medicinae |
| MU Faculty or unit | |
| Citation | |
| Web | https://doi.org/10.1145/3152124 |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | heart failure; pharmacotherapy; ACE inhibitors; sacubitril/valsartan; betablockers; diuretics; digoxin |
| Description | The main goal of heart failure treatment is to reduce mortality and morbidity, improve the quality of life and reduce the number of hospitalised patients. ACE inhibitors are the corner-stone of the treatment. Sartans are indicated in the case of ACE-I intolerance. ACE-I can be in future replaced with sacubitril/valsartan in symptomatic patients. Betablockers should be added to the renin angiotensin blockade in maximal tolerated doses. Diuretics are given to relieve symptoms such as dyspnoea or oedema. Adding digoxin is indicated in selected patients. |